Antibody-dependent cellular cytotoxicity (ADCC) is a mechanism of immune defense where an effector immune cell lyses a target cell whose surface antigens have been bound by specific antibodies. NK cells typically mediate ADCC through binding of antibodies via Fc receptors, which causes the NK cells to release cytotoxic factors that kill the target cell. ADCC requires antibodies produced during an adaptive immune response to coat the target cell, and can aid in limiting viral infection or killing tumor cells by lysing those coated cells.
Antibody-dependent cellular cytotoxicity (ADCC) is a mechanism of immune defense where an effector immune cell lyses a target cell whose surface antigens have been bound by specific antibodies. NK cells typically mediate ADCC through binding of antibodies via Fc receptors, which causes the NK cells to release cytotoxic factors that kill the target cell. ADCC requires antibodies produced during an adaptive immune response to coat the target cell, and can aid in limiting viral infection or killing tumor cells by lysing those coated cells.
Antibody-dependent cellular cytotoxicity (ADCC) is a mechanism of immune defense where an effector immune cell lyses a target cell whose surface antigens have been bound by specific antibodies. NK cells typically mediate ADCC through binding of antibodies via Fc receptors, which causes the NK cells to release cytotoxic factors that kill the target cell. ADCC requires antibodies produced during an adaptive immune response to coat the target cell, and can aid in limiting viral infection or killing tumor cells by lysing those coated cells.
The antibody-dependent cellular cytotoxicity (ADCC), also referred to as antibody-dependent cell-mediated cytotoxicity, is a mechanism of cell- mediated immune defense whereby an effector cell of the immune system actively lyses a target cell, whose membrane-surface antigens have been bound by specific antibodies.[1] It is one of the mechanisms through which antibodies, as part of the humoral immune response, can act to limit and contain infection.[2]
ADCC is independent of the immune
complement system that also lyses targets but does not require any other cell. ADCC requires an effector cell which classically is known to be natural killer (NK) cells that typically interact with IgG antibodies.[3] However, macrophages, neutrophils and eosinophils can also mediate ADCC, such as eosinophils killing certain parasitic worms known as helminths via IgE antibodies.[4]
ADCC is part of the adaptive immune
response due to its dependence on a prior antibody response. The coating of target cells with antibodies is sometimes referred to as opsonization. By NK cells The typical ADCC involves activation of NK cells by antibodies. A NK cell expresses Fc receptors, mostly CD16. These receptors recognize, and bind to, the Fc portion of an antibody, such as IgG, which has bound to the surface of a pathogen-infected target cell. The most common Fc receptor on the surface of an NK cell is called CD16 or FcγRIII. Once the Fc receptor binds to the Fc region of IgG, the Natural Killer cell releases cytotoxic factors that cause the death of the target cell.
During replication of a virus some of the
viral proteins are expressed on the cell surface membrane of the infected cell. Antibodies can then bind to these viral proteins. Next, the NK cells which have Fc Receptors will bind to that antibody, inducing the NK cell to release proteins such as perforin and proteases known as granzymes, which causes the lysis of the infected cell to hinder the spread of the virus.
Furthermore, NK cells are involved in
killing tumor cells and other cells that may lack MHC I on their surface, indicating a non-self cell. This is because, generally, all nucleated cells (which excludes RBCs) of the body contain MHC I.